Leigh Syndrome Treatment Market Global Demand, Opportunities, Top Key Players and Forecast to 2030
The Leigh Syndrome Treatment Market is expected to reach USD 192.62 Million by 2030 at 6.20% CAGR during the forecast period 2030 . Leigh’s disease is a progressive neurometabolic disorder occurring often after a viral infection during childhood, however, it can also occur in teens and adults. It is usually diagnosed with the help of MRI of the brain, particularly of the midbrain and brainstem part. The child often appears normal at birth but symptoms begin to appear within a few months to a period of two years of age. These may be accompanied by other problems such as irritability, loss of appetite, vomiting, and seizures. Eventually, the child may also have heart, kidney, vision, and breathing complications. There are different forms of Leigh's disease, but all forms have a poor prognosis. Those with partial deficiencies have a better prognosis but may live to be 6 or 7 years of age. Most cases are fatal during childhood, although some individuals have survived to adolescence.